Successful immunomodulatory therapy in @entity12692 with XXXX .

@entity1 @entity650 @entity1071 @entity419 @entity7271 @entity5 @entity12692 @entity2816 @entity134 @entity205
@entity12692 is a rare @entity1071 . The clinical signs and symptoms of the disease are primarily mediated by cytokines, especially @entity650 . We presented the case of a young female. In May 2004, a 30-year-old otherwise healthy looking @entity1 presented with oral ulcerations resistant to topical and systemic antibiotic and antimycotic treatment. Bullous mucosal lichen or @entity7271 were suspected. Histological examination and direct and indirect immunofluorescence confirmed the diagnosis of @entity7271 . Search for @entity5 revealed a retroperitoneal @entity5 sized 15 x 6 x 5 cm in the abdominal MRI. The @entity5 was a bleeder, so the removal was partial. Histological examination showed @entity12692 . Considering her young, fertile age and the multicentric @entity12692 , non-cytostatic immunomodulatory therapy was started including @entity134 , @entity205 and @entity2816 treatment. The control abdominal CT showed a small @entity5 on the bladder. The @entity5 was removed in repeated surgery. At this time the histological examination showed @entity5 between plasma cell and vascular variant. Currently, i.e. 4 years after the onset of the disease. @entity419 PET/CT examination showed low metabolic active mass in the right iliacal region, but our @entity1 had no symptoms or complaints. She is on 200 mg @entity2816 a day and no @entity5 progression can be seen. @entity12692 can be successfully treated with non-cytostatic immunomodulatory therapy.
